Top 5 Stocks to Buy Now
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free AGY Stock Alerts

Allergy Therapeutics (AGY) Stock Chart & Stock Price History

Allergy Therapeutics logo
GBX 7.50 +0.24 (+3.31%)
As of 05:45 AM Eastern
Compare

Allergy Therapeutics Stock Price Performance

The Allergy Therapeutics (AGY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 7.14%, with a year-to-date return of -33.04%. In the past month, the stock has decreased 16.67%, reflecting recent market activity.

As of the latest close, Allergy Therapeutics traded at GBX 7.26 with a market cap of £443.28 million and volume of 168,837 shares. Five years ago, the stock traded at GBX 24.60, representing a 69.51% decrease over that period. At the time, it had a market cap of £157.88 million and a volume of 47,277 shares.

Receive AGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+0.27%
1 Month
Performance
-16.67%
3 Month
Performance
-21.47%
Year-To-Date
Performance
-33.04%
1 Year
Performance
+7.14%
5 Year
Performance
-69.51%

AGY Stock Chart for Tuesday, June, 23, 2026

AGY Chart by TradingView

Allergy Therapeutics Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
06/22/2026GBX 7GBX 7.26
+3.71%		GBX 7.50GBX 6.50168,837 shs£443.28 million
06/19/2026GBX 7.48GBX 7
-6.42%		GBX 7.50GBX 6.50271,863 shs£443.28 million
06/18/2026GBX 7.50GBX 7.48
-0.27%		GBX 7.50GBX 6.80102,079 shs£473.67 million
06/17/2026GBX 7.50GBX 7.50GBX 7.50GBX 6.50203,060 shs£474.94 million
06/16/2026GBX 7.90GBX 7.50
-5.06%		GBX 8GBX 7811,525 shs£474.94 million
06/15/2026GBX 7.97GBX 7.90
-0.88%		GBX 8GBX 7.50521,191 shs£500.27 million
06/12/2026GBX 8GBX 7.97
-0.38%		GBX 8.50GBX 7.60210,307 shs£504.70 million
06/11/2026GBX 8.40GBX 8
-4.76%		GBX 8.50GBX 7.6747,689 shs£506.60 million
06/10/2026GBX 8.48GBX 8.40
-0.94%		GBX 8.50GBX 7.60487,459 shs£531.93 million
06/09/2026GBX 8.86GBX 8.48
-4.29%		GBX 9GBX 8.01361,814 shs£537.00 million
06/08/2026GBX 8.50GBX 8.86
+4.24%		GBX 9GBX 887,802 shs£561.06 million
06/05/2026GBX 8.90GBX 8.50
-4.49%		GBX 9GBX 8358,865 shs£538.27 million
06/04/2026GBX 8.70GBX 8.90
+2.30%		GBX 8.90GBX 8.5136,636 shs£563.60 million
06/03/2026GBX 8.50GBX 8.70
+2.35%		GBX 9.20GBX 8.70149,380 shs£550.93 million
06/02/2026GBX 9.28GBX 8.50
-8.41%		GBX 9.50GBX 8.50424,999 shs£538.27 million
06/01/2026GBX 9GBX 9.28
+3.11%		GBX 9.50GBX 8.50222,684 shs£587.66 million
05/29/2026GBX 9GBX 9GBX 9GBX 8.50198,754 shs£569.93 million
05/28/2026GBX 9GBX 9GBX 9.50GBX 8.50389,221 shs£569.93 million
05/27/2026GBX 9.10GBX 9
-1.10%		GBX 9.73GBX 8.581.27 million shs£569.93 million
05/26/2026GBX 9GBX 9.10
+1.11%		GBX 9.50GBX 8.50631,081 shs£576.26 million
05/25/2026GBX 9GBX 9GBX 10GBX 9543,248 shs£569.93 million
05/22/2026GBX 9.48GBX 9
-5.06%		GBX 10GBX 9543,248 shs£600.32 million
Related Companies

This page (LON:AGY) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel